Merck Launches Tender Offer to Acquire Terns Pharmaceuticals, Inc. Merck & Co., Inc., known as MSD outside the United States and Canada, has officially launched a cash tender offer through…
Allergan Aesthetics Launches Its Third Advanced AMI Training Center in Austin Allergan Aesthetics, a leading global provider of aesthetic medicine solutions and part of AbbVie, has announced the opening of…
enGene Confirms Corporate Name Change to enGene Therapeutics Inc enGene Therapeutics Inc., a clinical-stage biotechnology company focused on the development of non-viral genetic medicines, has announced that it will officially…
Biocon Announces U.S. Commercial Debut of Bosaya™ and Aukelso™, Its Denosumab Biosimilars Biocon Limited, a global innovation-driven biopharmaceutical organization, has announced the commercial launch of two denosumab biosimilars—Bosaya™ and Aukelso™—in…
Shionogi Highlights Real-World Effectiveness of Fetroja/Fetcroja Against MBL-Producing Enterobacterales at ESCMID Global 2026 Shionogi & Co., Ltd. has unveiled new real-world and surveillance data highlighting the clinical utility of cefiderocol…
Gilead to Acquire Tubulis to Enhance Oncology Portfolio with Potentially Best-in-Class ADC and Advanced Platform Gilead Sciences has announced that it has entered into a definitive agreement to acquire Tubulis…
B Capital Selected by AMED as Registered VC to Advance Japan’s Drug Development Ecosystem B Capital, a multi-stage investment firm with a strong focus on healthcare innovation, has announced that…
Acadia Pharmaceuticals Expands U.S. Access to DAYBUE STIX for Patients with Rett Syndrome Acadia Pharmaceuticals has announced that DAYBUE® STIX (trofinetide) for oral solution—a newly developed powder formulation of its…
CaryHealth Introduces Direct-to-Patient Access Program for Natroba in Collaboration with Cipher Pharmaceuticals CaryHealth, a leading provider of integrated digital healthcare solutions, has announced the launch of a new direct-to-patient (DTP)…
TriSalus Life Sciences Names Richard Marshall, MD, Chief Medical Officer TriSalus Life Sciences, a clinical-stage oncology company focused on integrating innovative drug delivery technologies with standard-of-care therapies and immunotherapeutic approaches,…
Amy Koch Joins Propel Health Medical Affairs as Senior Vice President, Client Services Propel Health Medical Affairs (PHMA), a full-service scientific communications agency operating within the broader Propel Health ecosystem,…
Endospan Secures U.S. Food and Drug Administration Approval for NEXUS® Aortic Arch Stent Graft System Endospan, a privately held innovator focused on advancing endovascular therapies for complex aortic conditions, has…